While breast cancer patients undergoing active therapy did not show significant differences in CRP levels by MBSR [60], breast cancer patients after active therapy (e.g., surgery) exhibited significant improvements in immune function by MBIs [61,62,63]. This evidence concerns the gene CRP and breast carcinoma.